Nanalysis Scientific announces $2.5 million private placement

Nanalysis Scientific Corp. (TSXV: NSCI) announced plans to complete a non-brokered private placement of up to 16,666,667 units at $0.15 per unit for gross proceeds of up to $2.5 million. The company will use net proceeds for debt reduction.

Each unit consists of one common share and one-half of one common share purchase warrant. Each whole warrant allows the holder to acquire one share at $0.20 per share within two years from the closing date.

The warrants include an acceleration provision. If the shares close at or above $0.30 for 10 consecutive trading days on the TSX Venture Exchange, the company may accelerate the warrant expiry date to 30 days after providing notice.

The offering requires TSX Venture Exchange acceptance and other customary closing conditions. The initial closing is anticipated on or around December 15, 2025, with the possibility of multiple tranches. All securities will be subject to a four-month and one-day statutory hold period.

Calgary-based Nanalysis develops and manufactures portable Nuclear Magnetic Resonance spectrometers for pharmaceutical, biotechnology, energy, food, materials, and security industries, as well as academic and government laboratories. The company operates a services division that maintains imaging equipment under a $160 million long-term contract with the Canadian Air Transport Security Authority to service security scanners at more than 80 Canadian airports.

The company trades on the TSX Venture Exchange under NSCI, the OTCQX market as NSCIF, and the Frankfurt Stock Exchange as 1N1.

You May Also Be Interested In

• Triumph Gold announces $5.4 million private placement
• Parabilis Medicines closes $770.5 million IPO and concurrent private placement
• OpenAI to acquire cloud platform ona to support ai agents - Bloomberg